GlaxoSmithKline scores retail deal with CVS, spreading Shingrix to thousands of pharmacies
GlaxoSmithKline has a lot riding on Shingrix, its new shingles vaccine. It's one of the key products CEO Emma Walmsley cited as growth drivers for the languishing c...


















